Health & Fitness
Health and Fitness
Health and Fitness 
Thu, February 17, 2011
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - Market Wire
[ Thu, Feb 17th 2011
] - WOPRAI
[ Thu, Feb 17th 2011
] - Market Wire
Vidaza ontvangt positieve Final Appraisal Determination van National Institute for Health and Clinical Excellence (NICE) voor g
BOUDRY, Switzerland--([ BUSINESS WIRE ])--Celgene International Srl, een volledige dochter van Celgene Corporation (Nasdaq:CELG) maakt vandaag bekend dat VIDAZA een Final Appraisal Determination (FAD) heeft ontvangen van het National Institute for Health and Clinical Excellence (NICE) waarin VIDAZA binnen de gelicenseerde indicatie wordt aangeraden als mogelijke behandeling voor patinten met het myelodysplastisch syndroom en acute myelode leukemie in Engeland en Wales. VIDAZA is het eerste en enige medicijn waarvan bewezen is dat het het leven van patinten met MDS kan verlengen.
Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.